Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debabrata Mukherjee

Showing results (11-20 of 574) with videos related to

Pageof 58
Sort By:
Archives of Internal Medicine|September 5, 2012
Perfluorooctanoic acid exposure and cardiovascular disease: potential role and preventive measures: comment on "Perfluorooctanoic acid and cardiovascular disease in US adults"Debabrata Mukherjee
Annals of Internal Medicine|August 18, 2020
After revascularization for PAD, rivaroxaban reduced vascular events with a small increase in major bleedingDebabrata Mukherjee
Annals of Internal Medicine|January 22, 2014
ACP Journal Club. Review: antiplatelet therapies are more effective in smokers than nonsmokersDebabrata Mukherjee
Annals of Internal Medicine|September 4, 2023
In HF, with or without PAD, dapagliflozin reduced a composite of worsening HF or CV death and did not increase amputationsDebabrata Mukherjee
Cardiovascular & Hematological Agents in Medicinal Chemistry|May 8, 2020
Cardiovascular and Hematological Medicine in 2020 - Advances and InsightsDebabrata Mukherjee
Lancet (London, England)|June 14, 2011
Antithrombotics and stent type for primary PCIDebabrata Mukherjee
Annals of Internal Medicine|September 16, 2015
Review: After coronary DES placement, longer vs shorter DAPT increases major bleeding and death and reduces MIDebabrata Mukherjee
Indian Heart Journal|January 6, 2009
Designing and performing large multicenter randomized clinical trials in India: what do we need?Debabrata Mukherjee
Cardiovascular & Hematological Agents in Medicinal Chemistry|January 24, 2012
Keeping up with advances in cardiovascular and hematological medicine in 2012Debabrata Mukherjee
JAMA Network Open|February 15, 2020
Coronary Revascularization in the United States-Patient Characteristics and Outcomes in 2020Debabrata Mukherjee
Pageof 58

Showing results (11-20 of 574) with videos related to

Sort By:
Pageof 58
Archives of Internal Medicine|September 5, 2012
Perfluorooctanoic acid exposure and cardiovascular disease: potential role and preventive measures: comment on "Perfluorooctanoic acid and cardiovascular disease in US adults"Debabrata Mukherjee
Annals of Internal Medicine|August 18, 2020
After revascularization for PAD, rivaroxaban reduced vascular events with a small increase in major bleedingDebabrata Mukherjee
Annals of Internal Medicine|January 22, 2014
ACP Journal Club. Review: antiplatelet therapies are more effective in smokers than nonsmokersDebabrata Mukherjee
Annals of Internal Medicine|September 4, 2023
In HF, with or without PAD, dapagliflozin reduced a composite of worsening HF or CV death and did not increase amputationsDebabrata Mukherjee
Cardiovascular & Hematological Agents in Medicinal Chemistry|May 8, 2020
Cardiovascular and Hematological Medicine in 2020 - Advances and InsightsDebabrata Mukherjee
Lancet (London, England)|June 14, 2011
Antithrombotics and stent type for primary PCIDebabrata Mukherjee
Annals of Internal Medicine|September 16, 2015
Review: After coronary DES placement, longer vs shorter DAPT increases major bleeding and death and reduces MIDebabrata Mukherjee
Indian Heart Journal|January 6, 2009
Designing and performing large multicenter randomized clinical trials in India: what do we need?Debabrata Mukherjee
Cardiovascular & Hematological Agents in Medicinal Chemistry|January 24, 2012
Keeping up with advances in cardiovascular and hematological medicine in 2012Debabrata Mukherjee
JAMA Network Open|February 15, 2020
Coronary Revascularization in the United States-Patient Characteristics and Outcomes in 2020Debabrata Mukherjee
Pageof 58